Ethical Compliance
KILITCH DRUGS INDIA
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
1.1%
Debt
13.2%
Liquidity
8.2%
Revenue
Debt
Liquidity
1.1%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Other Operating Revenue | ₹0.77 |
| Pharmaceuticals Products | ₹153.61 |
| Other Income | ₹2.67 |
Questionable
INR Crores
| Net Gain on Sale of Investments | ₹1.40 |
Non Compliant
INR Crores
| Interest income | ₹0.41 |
INR Crores
| Revenue from Questionable Sources: | ₹1.40 |
| Revenue from Non Compliant Sources: | ₹0.41 |
| Total: | ₹1.81 |
| Total Revenue: | ₹158.85 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹1.81
₹158.85
= 1.1%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
